SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides STANDARD i, an analyzer based on chemiluminescence immunoassay technology for detection of clinical biomarkers, including hormones, tumor markers, and infectious diseases; blood glucose meter products; and other products, such as transport medium, d-BLOCK incubator, G6PD analyzer, LipidoCare analyzer, MultiCare analyzer, and Pilot COVID-19 at-home test. The company exports its products. SD Biosensor, Inc. was founded in 1999 and is headquartered in Suwon-si, South Korea.
तुलना करने के लिए मीट्रिक्स | 137310 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध137310पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 9.5x | 12.0x | −0.6x | |
PEG अनुपात | 0.03 | 0.41 | 0.00 | |
क़ीमत/बुक | 0.4x | 1.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.5x | 1.9x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | −0.2% | 42.9% | 44.9% | |
उचित मूल्य अपसाइड | अनलॉक करें | 24.7% | 6.7% | अनलॉक करें |